section name header

Evidence summaries

The Effect of Statins on Mortality and the Incidence of Coronary Events in Secondary Prevention of Ischaemic Heart Disease

Simvastatin treatment is effective in decreasing the incidence of nonfatal myocardial infarction, need for coronary surgery and mortality in ischaemic heart disease in patients with angina pectoris or previous myocardial infarction. Level of evidence: "A"

The 4S trial 1 included 4 444 patients with angina pectoris or previous myocardial infarction and serum cholesterol 5.5-8.0 mmol/L on a lipid-lowering diet. They were randomised to double-blind treatment with simvastatin or placebo. During an average follow-up period of 5.4 years the incidence of nonfatal myocardial infarction decreased (relative risk 0.66, 95% CI 0.59 - 0.75, p < 0.00001) compared to a placebo, the need for coronary surgery decreased by 37% (p < 0.00001), and mortality in ischaemic heart disease decreased (relative risk 0.58, 95% CI 0.46 - 0.73). Total mortality decreased by 30%. The decrease was totally explained by the decrease in IHD mortality. The benefit of treatment was evident in both men and women, both in the young and in the elderly (aged 65 years or above), and the effect was not dependent on baseline cholesterol concentration.

    References

Primary/Secondary Keywords